By contrast to most previous studies, herein, statistically significant several-fold lower levels of soluble TNFR1 and TNFR2 were observed in untreated OSA patients relative to control subjects. The gene discussed is TNFRSF1A; the disease is obstructive sleep apnea syndrome.